Your browser doesn't support javascript.
loading
Effect of compensatory evolution in the emergence and transmission of rifampicin-resistant Mycobacterium tuberculosis in Cape Town, South Africa: a genomic epidemiology study.
Goig, Galo A; Menardo, Fabrizio; Salaam-Dreyer, Zubeida; Dippenaar, Anzaan; Streicher, Elizabeth M; Daniels, Johnny; Reuter, Anja; Borrell, Sonia; Reinhard, Miriam; Doetsch, Anna; Beisel, Christian; Warren, Robin M; Cox, Helen; Gagneux, Sebastien.
Affiliation
  • Goig GA; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland. Electronic address: galo.goig@swisstph.ch.
  • Menardo F; Department of Plant and Microbial Biology, University of Zürich, Zürich, Switzerland.
  • Salaam-Dreyer Z; Division of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Dippenaar A; Tuberculosis Omics Research Consortium, Family Medicine and Population Health, Institute of Global Health, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
  • Streicher EM; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Stellenbosch, South Africa; South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetic
  • Daniels J; Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa.
  • Reuter A; Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa.
  • Borrell S; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
  • Reinhard M; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
  • Doetsch A; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
  • Beisel C; Department of Biosystems Science and Engineering, Eidgenössische Technische Hochschule Zürich, Zürich, Swizterland.
  • Warren RM; Department of Science and Innovation - National Research Foundation Centre of Excellence for Biomedical Tuberculosis Research, Stellenbosch University, Stellenbosch, South Africa; South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetic
  • Cox H; Division of Medical Microbiology, Department of Pathology, University of Cape Town, Cape Town, South Africa; Institute of Infectious Disease and Molecular Medicine and Wellcome Centre for Infectious Disease Research, University of Cape Town, Cape Town, South Africa.
  • Gagneux S; Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.
Lancet Microbe ; 4(7): e506-e515, 2023 07.
Article de En | MEDLINE | ID: mdl-37295446

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose multirésistante / Mycobacterium tuberculosis Type d'étude: Prognostic_studies / Screening_studies Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Lancet Microbe Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose multirésistante / Mycobacterium tuberculosis Type d'étude: Prognostic_studies / Screening_studies Limites: Humans Pays/Région comme sujet: Africa Langue: En Journal: Lancet Microbe Année: 2023 Type de document: Article